Its induction can be either mitogen-activated protein kinase dependent (in LNCaP prostate cancer cells) or phosphoinositide-3 kinase dependent (in MDA-MB231 basal-like breast cancer cells and HCT-116 colon cancer cells). Here, WNK2 is linked to prostate carcinoma.